The Latest Treatment for Rheumatoid Arthritis

Latest Treatment for Rheumatoid Arthritis

On June 1, 2018, the U.S. Food and Drug Administration (FDA) approved the use of Baricitinib, commonly known as Olumiant, for the treatment of rheumatoid arthritis in adult patients who have not achieved adequate responses to one or more Tumor Necrosis Factor (TNF) inhibitors. It is important to note that Baricitinib is indicated for the management of moderate to severe rheumatoid arthritis.

Other Treatments for Rheumatoid Arthritis

Pharmacological Treatments

The selection of an appropriate medication for the treatment of rheumatoid arthritis depends on the severity of symptoms and the duration since diagnosis. The following are key medication options:

  • Disease-Modifying Antirheumatic Drugs (DMARDs): These medications help preserve joints and other tissues from permanent damage, while also slowing the progression of rheumatoid arthritis. Examples include Sulfasalazine, Hydroxychloroquine, Leflunomide, and Methotrexate.
  • Corticosteroids: These drugs alleviate inflammation and pain associated with rheumatoid arthritis and can slow joint damage. A common example is Prednisone.
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): This group aids in reducing pain and inflammation linked to rheumatoid arthritis. Examples of over-the-counter NSAIDs include Ibuprofen and Naproxen Sodium.

Home Remedies

Several home remedies may help alleviate the symptoms of rheumatoid arthritis, including:

  • Rest: Ensuring adequate rest can help reduce inflammation and pain associated with disease flare-ups.
  • Regular Exercise: Light physical activity can strengthen muscles and improve joint flexibility.
  • Heat and Cold Therapy: Applying heat or cold can relieve pain, reduce inflammation, and lessen muscle spasms.
  • Improving Diet: Consuming foods rich in Omega-3 fatty acids, such as fish and flaxseeds, along with antioxidant-rich foods like spinach and blueberries, can be beneficial.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top